SI1147101T1 - Reverse hydroxamate inhibitors of matrix metalloproteinases - Google Patents

Reverse hydroxamate inhibitors of matrix metalloproteinases

Info

Publication number: SI1147101T1
Authority: SI; Slovenia
Prior art keywords: matrix metalloproteinases; hydroxamate inhibitors; reverse hydroxamate; reverse; inhibitors
Prior art date: 1999-01-27

Application number

SI200030041T

Other languages

Slovenian (sl)

Inventor

Michael L. Curtin

Yujia Dai

Steven K. Davidsen

Howard R. Heyman

James H. Holmes

Michael R. Michaelides

Douglas H. Steinman

Original Assignee

Abbott Laboratories

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-27

Filing date

2000-01-27

Publication date

2003-06-30

2000-01-27 Application filed by Abbott Laboratories filed Critical Abbott Laboratories

2000-01-27 Priority claimed from PCT/US2000/002038 external-priority patent/WO2000044739A1/en

2003-06-30 Publication of SI1147101T1 publication Critical patent/SI1147101T1/en

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US23908799A	1999-01-27	1999-01-27
PCT/US2000/002038 WO2000044739A1 (en)	1999-01-27	2000-01-27	Reverse hydroxamate inhibitors of matrix metalloproteinases
EP00905758A EP1147101B1 (en)	1999-01-27	2000-01-27	Reverse hydroxamate inhibitors of matrix metalloproteinases

Publications (1)

Publication Number	Publication Date
SI1147101T1 true SI1147101T1 (en)	2003-06-30

Family

ID=27664965

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200030041T SI1147101T1 (en)	1999-01-27	2000-01-27	Reverse hydroxamate inhibitors of matrix metalloproteinases

Country Status (1)

Country	Link
SI (1)	SI1147101T1 (en)

2000
- 2000-01-27 SI SI200030041T patent/SI1147101T1/en unknown

Similar Documents

Publication	Publication Date	Title
IL149118A0 (en)	2002-11-10	Inhibitors of neuraminidases
IL150712A0 (en)	2003-02-12	Matrix metalloproteinase inhibitors
EP1361873A4 (en)	2005-10-26	Matrix metalloproteinase inhibitors
PL350193A1 (en)	2002-11-18	Sulfamato hydroxamic acid metalloprotease inhibitor
HK1057746A1 (en)	2004-04-16	Hydroxamate derivatives useful as deacetylase inhibitors
IL138738A0 (en)	2001-10-31	Substituted pyrrolidine hydroxamate metalloprotease inhibitors
HK1045501A1 (en)	2002-11-29	Hydroxamic acid derivatives as matrix metalloprotease inhibitors
AU6764400A (en)	2001-03-13	Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors
AU2001265182A1 (en)	2001-12-11	Inhibitors of matrix metalloproteinases
HK1046289A1 (en)	2003-01-03	Prodrugs of thrombin inhibitors
IL131047A0 (en)	2001-01-28	Use of il-18 inhibitors
PL349771A1 (en)	2002-09-09	Reverse hydroxamate inhibitors of matrix metalloproteinases
AU2001241498A1 (en)	2001-08-27	Matrix metalloproteinase inhibitors and uses thereof
PL357084A1 (en)	2004-07-12	Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
AU2001274344A1 (en)	2002-01-30	Tissue inhibitors of matrix metalloproteinases
HUP0302904A3 (en)	2005-02-28	Matrix metalloproteinase inhibitors
SG119168A1 (en)	2006-02-28	Utilization of at least one aminopeptidase inhibitor
AU8005100A (en)	2001-04-30	Inhibitors of neuraminidases
SI1147101T1 (en)	2003-06-30	Reverse hydroxamate inhibitors of matrix metalloproteinases
GB9708133D0 (en)	1997-06-11	Novel use of matrix metalloproteinase inhibitors
HUP0202431A3 (en)	2003-03-28	Prodrugs of thrombin inhibitors
GB9822950D0 (en)	1998-12-16	Therapeutic use of matrix metalloproteinase inhibitors
GB9927780D0 (en)	2000-01-26	The therapeutic use of matrix metalloproteinase inhibitors
GB9818841D0 (en)	1998-10-21	Pharmaceutical use of protease inhibitors
IL147675A0 (en)	2002-08-14	Use of il-18 inhibitors